Dillon C. Cockrell

Dillon C. Cockrell

Hematology Oncology | Hematology | Oncology

216 Ashville Ave
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

Journal: Research square

Published: July 10, 2026

Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

Journal: Prostate cancer and prostatic diseases

Published: March 09, 2026

Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF Trial.

Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF Trial.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education

Published: October 31, 2025

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial.

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial.

Journal: JCO oncology practice

Published: May 31, 2025

Supporting our survivors: an evaluation of the facilitators and barriers to advocacy in cervical and breast cancer survivors.

Supporting our survivors: an evaluation of the facilitators and barriers to advocacy in cervical and breast cancer survivors.

Journal: The oncologist

Published: December 17, 2024

Correction to: Current Status of Perioperative Therapy in Muscle‑Invasive Bladder Cancer and Future Directions.

Correction to: Current Status of Perioperative Therapy in Muscle‑Invasive Bladder Cancer and Future Directions.

Journal: Current oncology reports

Published: April 20, 2023

Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions.

Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions.

Journal: Current oncology reports

Published: January 28, 2023

Emergency department visits and hospitalizations in older women treated for early stage breast cancer.

Emergency department visits and hospitalizations in older women treated for early stage breast cancer.

Journal: Journal of geriatric oncology

Published: September 13, 2022

Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab.

Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 17, 2022

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature.

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature.

Journal: Case reports in oncology

Published: August 19, 2020

Predictors of Time to Metastasis in Castration-resistant Prostate Cancer.

Predictors of Time to Metastasis in Castration-resistant Prostate Cancer.

Journal: Urology

Published: February 01, 2016

Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH.

Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH.

Journal: Clinical genitourinary cancer

Published: January 04, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026